The landscape of central nervous system (CNS) stimulants underwent a drastic shift during the late 2000s and early 2010s. This era marked the rapid rise of synthetic designer molecules, widely sold online and in retail establishments under ambiguous marketing labels. Among the most potent and highly scrutinized compounds of this generation is Methylenedioxypyrovalerone (MDPV) UK […]